Comparison

Influenza A H1N1 (Reassortant) Protein (1ml)

Item no. OPMA04542
Manufacturer AVIVA Systems Biology
Amount 1 ml
Category
Type Proteins Recombinant
Specific against other
Host Chicken
Purity Eggs are infected by injection into the Allantoic chamber, incubated for 72 hours, and refrigerated overnight prior to harvest. Allantoic fluids are harvested from the eggs and pooled.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Influenza A Strain A/California/7/2009 NYMC X-179A (H1N1)v
Available
Description
Influenza A H1N1 (Reassortant) Influenza A Strain A/California/7/2009 NYMC X-179A (H1N1)v Attenuated reassortant vaccine candidate strain of reduced pathogenicity relative to the wild typeA/California/4/2009 virus. Contains a high concentration of viral antigens as well as some egg proteins(Allantoic fluid). Reassortant virus includes genetic components of the H1N1 influenza pandemic swine flu in a culture-adapted virus that has been selected for its qualities as a vaccine-producing strain.
Reconstitution and storage
Store at -70C to -100C. Avoid multiple freeze/thaw cycles.
Manufacturer - Specificity
Influenza A Strain A/California/7/2009 NYMC X-179A (H1N1)v

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close